This episode of AXREM Insights focuses on cardiovascular disease as a major global health challenge and explores how advances in imaging, AI and medical technology are reshaping its detection and management. Host Sally Edgington and guest host Giulia Ginami are joined by Dr Sohaib Nazir, who shares insights from both clinical practice and academic research. The conversation highlights the growing importance of early detection and prevention, with imaging playing a central role in identifying disease before symptoms appear. Innovations in CT, MRI and ultrasound, alongside AI-driven analysis, are already improving diagnostic accuracy and efficiency, but challenges remain around adoption, funding and integrating these tools into everyday clinical pathways.

The discussion also looks at the wider system pressures facing clinicians, including administrative burden, fragmented IT systems and limited interoperability across NHS trusts, all of which can delay diagnosis and treatment. Dr Nazir emphasises the need for better use of existing data, more streamlined processes and stronger collaboration between industry, academia and healthcare providers to close the gap between innovation and patient care. Looking ahead, the episode explores the increasing complexity of patient needs, particularly with rising multi-morbidity and the intersection of conditions such as cancer and cardiovascular disease. Ultimately, the conversation calls for a more proactive, data-driven and collaborative approach to improve patient outcomes and ensure the healthcare system is equipped for the future.

Join AXREM and Convenzis at Radvision South at the ETC Venues in London on the 8th of July. Book your ticket here

Join us for the AXREM External Stakeholders Conference on 14th of October at the Royal society of Medicine in London. Book your ticket here

Thanks for listening to this week's episode

To find out more about AXREM check out our website HERE
If you are interested in joining AXREM as a member CLICK HERE
To contact us CLICK HERE

And join us next time for more insights from industry.

This episode of AXREM Insights focuses on the current state of the UK stroke pathway, featuring insights from Michelle Dalmacio of the Stroke Association. The discussion highlights the scale of the challenge, with over 100,000 strokes each year and growing demand placing pressure on services. While effective treatments such as thrombectomy can significantly improve recovery and reduce disability, access remains inconsistent, with only a small percentage of eligible patients receiving it and limited 24/7 availability across centres. The conversation explores how workforce shortages, regional inequalities, and gaps in community rehabilitation continue to impact patient outcomes, reinforcing the need for coordinated national action.

Alongside these challenges, the episode emphasises the opportunity for innovation to transform stroke care. Advanced imaging, AI-driven decision-making, and tele-radiology are presented as key tools to support faster diagnosis, better triage, and more equitable access to specialist treatment. The importance of the full care pathway is a central theme, particularly the role of rehabilitation and community support in long-term recovery. The episode also underlines the importance of public awareness, encouraging recognition of stroke symptoms through the FAST test and stressing that stroke is a medical emergency where rapid action can save lives and improve outcomes.

View our State of the Stroke Pathway paper here

Join AXREM and Convenzis at Radvision South at the ETC Venues in London on the 8th of July. Book your ticket here

Join us for the AXREM External Stakeholders Conference on 14th of October at the Royal society of Medicine in London. Book your ticket here

Thanks for listening to this week's episode

To find out more about AXREM check out our website HERE
If you are interested in joining AXREM as a member CLICK HERE
To contact us CLICK HERE

And join us next time for more insights from industry.

In this episode of Axrem Insights, CEO Sally Edgington is joined by Holly Ruddock, Jack Bond and value-based procurement expert Brian Mangan, CEO of Luach Consulting Group, to unpack what value-based procurement really means for the NHS and industry. Moving beyond buzzwords, the panel explores how procurement can shift from a narrow focus on price to a broader assessment of patient pathways, long-term outcomes, efficiency gains and environmental impact. At its heart, value-based procurement is about delivering tangible, measurable benefits that improve care while making smarter use of limited resources.

The discussion tackles common barriers including siloed budgets, data access, cultural resistance and the perception that value-based approaches cost more. The panel highlights the growing policy momentum behind the agenda, including pilots and increased focus on outcomes, and makes the case that now is the time for suppliers to build evidence, develop case studies and reframe conversations with procurement teams. For AXREM members and NHS stakeholders alike, this episode offers a practical and optimistic look at how collaboration, communication and better questions can unlock real system-wide value.

AXREM Value Based Procurement Paper

Join AXREM and Convenzis at Radvision South at the ETC Venues in London on the 8th of July. Book your ticket here

Join us for the AXREM External Stakeholders Conference on 14th of October at the Royal society of Medicine in London. Book your ticket here

Thanks for listening to this week's episode

To find out more about AXREM check out our website HERE
If you are interested in joining AXREM as a member CLICK HERE
To contact us CLICK HERE

And join us next time for more insights from industry.